Orange Book product · Generic (ANDA)
MUPIROCIN
MUPIROCIN CALCIUM
At a glance
Nov 15, 2022
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 15, 2022
3 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
MUPIROCIN CALCIUM
Strength
EQ 2% BASE
Dosage form
CREAM
Route
TOPICAL
TE code
AB
Application
ANDA 214811
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of MUPIROCIN CALCIUM
- 1997BACTROBANBrand (NDA)
NDA 050746 · GLAXOSMITHKLINE
- 1995BACTROBANBrand (NDA)
NDA 050703 · GLAXOSMITHKLINE
- 2022MUPIROCINGeneric (ANDA)
ANDA 212465 · PADAGIS ISRAEL
- 2021MUPIROCINGeneric (ANDA)
ANDA 213053 · ALEMBIC
- 2021MUPIROCINGeneric (ANDA)
ANDA 213076 · ENCUBE
- 2020MUPIROCINGeneric (ANDA)
ANDA 207116 · SUN PHARMA CANADA
- 2013MUPIROCINGeneric (ANDA)
ANDA 201587 · GLENMARK PHARMS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
